uniQure
QURE
$4.95
Share price
5.77%
Change (1 day)
-75.97%
Change (1 year)
uniQure (QURE) - P/B ratio
P/B ratio as of June 2024 : 1.55
According to uniQure's latest financial reports the company has a price-to-book ratio of 1.55.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
uniQure - P/B ratio (from 2014 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 1.56 | -30.09% |
| 2022-12-31 | 2.23 | 38.59% |
| 2021-12-31 | 1.61 | -75.59% |
| 2020-12-31 | 6.59 | -32.02% |
| 2019-12-31 | 9.70 | 61.78% |
| 2018-12-31 | 5.99 | -11.24% |
| 2017-12-31 | 6.75 | 205.23% |
| 2016-12-31 | 2.21 | -29.67% |
| 2015-12-31 | 3.15 | -38.47% |
| 2014-12-31 | 5.11 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | 32.2 | 1,976.66% | 🇺🇸 USA |
 Sanofi SNY | 1.46 | -5.53% | 🇫🇷 France |
 Sangamo Therapeutics
SGMO | 2.12 | 36.61% | 🇺🇸 USA |
 bluebird bio
BLUE | 0.7781 | -49.74% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 2.81 | 81.36% | 🇺🇸 USA |
 Avidity Biosciences RNA | 3.11 | 101.17% | 🇺🇸 USA |